Immuneering Corporation (NASDAQ:IMRX) Q3 2025 Earnings Call Transcript
Operator: Welcome to the Immuneering Corporation Conference Call to discuss the company's Third Quarter 2025 financial results and share investigator-presented clinical case studies in pancreatic patients...



